Doyle Supports Patient Protection and Affordable Care Enhancement Act
Washington, DC – June 25, 2020 – U.S. Representative Mike Doyle (PA-18) announced his support for the Patient Protection and Affordable Care Enhancement Act, legislation unveiled Wednesday that would lower the costs of health care and prescription drugs, expand access to affordable health care, and strengthen protections for people with preexisting conditions.
“The lack of affordable health insurance prevents many Americans from seeking the health care they need, and it costs many others more than they can afford. Staying healthy and getting treatment in this country is a matter of dollars and cents - and it’s an impossible situation for far too many of our families, friends, and neighbors.
“That’s why Americans are demanding improvements in our broken health care system – and why I support the Patient Protection and Affordable Care Enhancement Act. This landmark legislation would reduce health insurance premiums, deductibles, and out-of-pocket expenses, lower the cost of prescription drugs, encourage states to expand their Medicaid programs to cover more vulnerable households, preserve the Affordable Care Act’s protections for people with preexisting conditions, and reduce maternal mortality among minority women.
“It’s essential that we enact the Patient Protection and Affordable Care Enhancement Act as soon as possible in order to deal with the COVID-19 pandemic and lower health care costs for the millions of Americans who are struggling these days to make ends meet.”
The Patient Protection and Affordable Care Enhancement Act would lower health insurance premiums by expanding eligibility for premium tax credits beyond 400 percent of the federal poverty line and increasing tax credits for all income brackets. It would also assist states in lowering deductibles and out-of-pocket costs for all Americans, and it would offer incentives for states to establish their own state-based marketplaces with lower premiums. Finally, it would create a national reinsurance program to cover the costs of patients with expensive medical conditions.
This legislation would reduce prescription drug costs by allowing Medicare to negotiate lower prices and making those prices available to all Americans with private health insurance. It would prevent drug companies from charging American consumers more than other countries for the same drugs.
In addition, this legislation would encourage states to expand their Medicaid programs, reverse the Trump Administration’s efforts to provide waivers to states that allow them to undermine ACA protections for pre-existing conditions, stop health insurance companies from offering junk insurance plans that discriminate against people with pre-existing conditions and put consumers at financial risk, and reverse the Trump Administration's funding cuts for outreach and support to make sure Americans are aware of their options for coverage.
Finally, this legislation would work to reduce the rate of maternal mortality among minority women by extending Medicaid and CHIP coverage for new mothers from the current 60 days to a full year. It would also protect low-income Americans from losing their health insurance due to inconsistent income by extending Medicaid and CHIP coverage for a full 12 months once someone is enrolled.
Earlier in the 116th Congress, House Democrats passed H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act; H.R. 2328, the Reauthorizing and Extending America’s Community Health Act, which would prohibit surprise billing, making sure that patients no longer receive huge unexpected bills; and legislation to protect against Republican sabotage of the Patient Protection and Affordable Care Act.
Congressman Doyle is also a cosponsor of H.R. 1384, the Medicare for All Act, which would provide universal health insurance coverage for all Americans.